Activeted-252831-2026

Pharmaceutical Contracts with Access Option

This tender covers contracts for various pharmaceuticals containing specific active ingredient combinations. BARMER is seeking reliable suppliers for these essential medications.

View original source

CONTRACTING AUTHORITY

Name

BARMER Beschaffung und Vergabe

City

Wuppertal

Country

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33600000 – Pharmaceutical products.

LOTS (5)

LOT-0001Supplies

Bimatoprost (MDO_0,1 mg_ml)

LOT-0002Supplies

Calcipotriol + Betamethason dipropionat (SCH)

LOT-0003Supplies

Eltrombopag (ausgenommen SAA)

LOT-0004Supplies

Eltrombopag (Revolade®)

LOT-0005Supplies

Nintedanib

ADDITIONAL DETAILS

EU Funded

Yes

Suitable for SMEs

Electronic Submission

allowed

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

05/01/202810:00 AM Uhr732 days remaining

(LOT-0001)

Published

04/13/2026

TENDER DOCUMENTS

732 days remaining

Similar Tenders

Explore CPV 33

Discount Agreements for Biologics (Biosimilars)

BARMER is seeking framework agreements for biotechnologically manufactured medicines (biosimilars). The goal is to establish discount contracts to reduce healthcare costs.

BARMER Beschaffung und Vergabe

·Wuppertal

Deadline:June 01, 2026

Framework Agreement for Pharmaceuticals with Accession Option

BARMER is establishing a framework agreement for various active ingredients with an accession option to ensure broad supply. This serves to inform pharmaceutical companies.

BARMER Beschaffung und Vergabe

·Wuppertal

Deadline:May 01, 2028

Drug Contracts with Accession Option

Contracts are sought for medications containing the active ingredients Lisdexamfetamine, Teriparatide, and Ustekinumab. The goal is to ensure patients have reliable access to these essential medicines.

BARMER Beschaffung und Vergabe

·Wuppertal

Deadline:May 01, 2026